IBDEI2SL ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46874,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,46875,0)
 ;;=L40.2^^206^2313^1
 ;;^UTILITY(U,$J,358.3,46875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46875,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,46875,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,46875,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,46876,0)
 ;;=L03.91^^206^2313^2
 ;;^UTILITY(U,$J,358.3,46876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46876,1,3,0)
 ;;=3^Acute Lymphangitis,Unspec
 ;;^UTILITY(U,$J,358.3,46876,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,46876,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,46877,0)
 ;;=L23.9^^206^2313^3
 ;;^UTILITY(U,$J,358.3,46877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46877,1,3,0)
 ;;=3^Allergic Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,46877,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,46877,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,46878,0)
 ;;=L03.90^^206^2313^4
 ;;^UTILITY(U,$J,358.3,46878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46878,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,46878,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,46878,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,46879,0)
 ;;=L02.91^^206^2313^7
 ;;^UTILITY(U,$J,358.3,46879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46879,1,3,0)
 ;;=3^Cutaneous Abscess,Unspec
 ;;^UTILITY(U,$J,358.3,46879,1,4,0)
 ;;=4^L02.91
 ;;^UTILITY(U,$J,358.3,46879,2)
 ;;=^5009016
 ;;^UTILITY(U,$J,358.3,46880,0)
 ;;=L30.2^^206^2313^8
 ;;^UTILITY(U,$J,358.3,46880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46880,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,46880,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,46880,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,46881,0)
 ;;=L30.9^^206^2313^10
 ;;^UTILITY(U,$J,358.3,46881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46881,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,46881,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,46881,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,46882,0)
 ;;=Z48.01^^206^2313^5
 ;;^UTILITY(U,$J,358.3,46882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46882,1,3,0)
 ;;=3^Change/Removal of Surgical Wound Dressing
 ;;^UTILITY(U,$J,358.3,46882,1,4,0)
 ;;=4^Z48.01
 ;;^UTILITY(U,$J,358.3,46882,2)
 ;;=^5063034
 ;;^UTILITY(U,$J,358.3,46883,0)
 ;;=L98.3^^206^2313^11
 ;;^UTILITY(U,$J,358.3,46883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46883,1,3,0)
 ;;=3^Eosinophilic Cellulitis
 ;;^UTILITY(U,$J,358.3,46883,1,4,0)
 ;;=4^L98.3
 ;;^UTILITY(U,$J,358.3,46883,2)
 ;;=^5009576
 ;;^UTILITY(U,$J,358.3,46884,0)
 ;;=L40.1^^206^2313^18
 ;;^UTILITY(U,$J,358.3,46884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46884,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,46884,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,46884,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,46885,0)
 ;;=L40.4^^206^2313^12
 ;;^UTILITY(U,$J,358.3,46885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46885,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,46885,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,46885,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,46886,0)
 ;;=L24.9^^206^2313^13
 ;;^UTILITY(U,$J,358.3,46886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46886,1,3,0)
 ;;=3^Irritant Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,46886,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,46886,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,46887,0)
 ;;=L30.0^^206^2313^14
 ;;^UTILITY(U,$J,358.3,46887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46887,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,46887,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,46887,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,46888,0)
 ;;=L40.8^^206^2313^15
